guest ::
| Home > Publications database > TET proteins regulate the lineage specification and TCR-mediated expansion of iNKT cells. > print |
| Home > Publications database > TET proteins regulate the lineage specification and TCR-mediated expansion of iNKT cells. > print |
| 001 | 119264 | ||
| 005 | 20240228145430.0 | ||
| 024 | 7 | _ | |2 doi |a 10.1038/ni.3630 |
| 024 | 7 | _ | |2 pmid |a pmid:27869820 |
| 024 | 7 | _ | |2 ISSN |a 1529-2908 |
| 024 | 7 | _ | |2 ISSN |a 1529-2916 |
| 024 | 7 | _ | |a altmetric:13890463 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2017-00050 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Tsagaratou, Ageliki |b 0 |
| 245 | _ | _ | |a TET proteins regulate the lineage specification and TCR-mediated expansion of iNKT cells. |
| 260 | _ | _ | |a New York, NY |b Nature America Inc. |c 2017 |
| 336 | 7 | _ | |2 DRIVER |a article |
| 336 | 7 | _ | |2 DataCite |a Output Types/Journal article |
| 336 | 7 | _ | |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) |a Journal Article |b journal |m journal |s 1511333508_28942 |
| 336 | 7 | _ | |2 BibTeX |a ARTICLE |
| 336 | 7 | _ | |2 ORCID |a JOURNAL_ARTICLE |
| 336 | 7 | _ | |0 0 |2 EndNote |a Journal Article |
| 520 | _ | _ | |a TET proteins oxidize 5-methylcytosine in DNA to 5-hydroxymethylcytosine and other oxidation products. We found that simultaneous deletion of Tet2 and Tet3 in mouse CD4(+)CD8(+) double-positive thymocytes resulted in dysregulated development and proliferation of invariant natural killer T cells (iNKT cells). Tet2-Tet3 double-knockout (DKO) iNKT cells displayed pronounced skewing toward the NKT17 lineage, with increased DNA methylation and impaired expression of genes encoding the key lineage-specifying factors T-bet and ThPOK. Transfer of purified Tet2-Tet3 DKO iNKT cells into immunocompetent recipient mice resulted in an uncontrolled expansion that was dependent on the nonclassical major histocompatibility complex (MHC) protein CD1d, which presents lipid antigens to iNKT cells. Our data indicate that TET proteins regulate iNKT cell fate by ensuring their proper development and maturation and by suppressing aberrant proliferation mediated by the T cell antigen receptor (TCR). |
| 536 | _ | _ | |0 G:(DE-HGF)POF3-312 |a 312 - Functional and structural genomics (POF3-312) |c POF3-312 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 700 | 1 | _ | |a González-Avalos, Edahí |b 1 |
| 700 | 1 | _ | |a Rautio, Sini |b 2 |
| 700 | 1 | _ | |a Scott-Browne, James P |b 3 |
| 700 | 1 | _ | |a Togher, Susan |b 4 |
| 700 | 1 | _ | |a Pastor, William A |b 5 |
| 700 | 1 | _ | |0 http://orcid.org/0000-0002-3901-347X |a Rothenberg, Ellen V |b 6 |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Chavez, Lukas |b 7 |
| 700 | 1 | _ | |a Lähdesmäki, Harri |b 8 |
| 700 | 1 | _ | |a Rao, Anjana |b 9 |
| 773 | _ | _ | |0 PERI:(DE-600)2026412-4 |a 10.1038/ni.3630 |g Vol. 18, no. 1, p. 45 - 53 |n 1 |p 45 - 53 |t Nature immunology |v 18 |x 1529-2916 |y 2017 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:119264 |p VDB |
| 910 | 1 | _ | |0 I:(DE-588b)2036810-0 |6 P:(DE-HGF)0 |a Deutsches Krebsforschungszentrum |b 7 |k DKFZ |
| 913 | 1 | _ | |0 G:(DE-HGF)POF3-312 |1 G:(DE-HGF)POF3-310 |2 G:(DE-HGF)POF3-300 |a DE-HGF |l Krebsforschung |v Functional and structural genomics |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
| 914 | 1 | _ | |y 2017 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0420 |2 StatID |a Nationallizenz |
| 915 | _ | _ | |0 StatID:(DE-HGF)0100 |2 StatID |a JCR |b NAT IMMUNOL : 2015 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0200 |2 StatID |a DBCoverage |b SCOPUS |
| 915 | _ | _ | |0 StatID:(DE-HGF)0300 |2 StatID |a DBCoverage |b Medline |
| 915 | _ | _ | |0 StatID:(DE-HGF)0310 |2 StatID |a DBCoverage |b NCBI Molecular Biology Database |
| 915 | _ | _ | |0 StatID:(DE-HGF)0600 |2 StatID |a DBCoverage |b Ebsco Academic Search |
| 915 | _ | _ | |0 StatID:(DE-HGF)0030 |2 StatID |a Peer Review |b ASC |
| 915 | _ | _ | |0 StatID:(DE-HGF)0199 |2 StatID |a DBCoverage |b Thomson Reuters Master Journal List |
| 915 | _ | _ | |0 StatID:(DE-HGF)0110 |2 StatID |a WoS |b Science Citation Index |
| 915 | _ | _ | |0 StatID:(DE-HGF)0150 |2 StatID |a DBCoverage |b Web of Science Core Collection |
| 915 | _ | _ | |0 StatID:(DE-HGF)0111 |2 StatID |a WoS |b Science Citation Index Expanded |
| 915 | _ | _ | |0 StatID:(DE-HGF)1030 |2 StatID |a DBCoverage |b Current Contents - Life Sciences |
| 915 | _ | _ | |0 StatID:(DE-HGF)1050 |2 StatID |a DBCoverage |b BIOSIS Previews |
| 915 | _ | _ | |0 StatID:(DE-HGF)9915 |2 StatID |a IF >= 15 |b NAT IMMUNOL : 2015 |
| 920 | 1 | _ | |0 I:(DE-He78)B062-20160331 |k B062 |l Pädiatrische Neuroonkologie |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)B062-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|